Management ChangeAug 3, 2026, 02:36 PM
Fresenius Medical Care Appoints Cassie McLean to Management Board
AI Summary
Fresenius Medical Care AG has appointed Cassie McLean to its Management Board, effective August 1, 2026. Ms. McLean will assume the role of Chief Executive Officer for the Care Delivery operating segment, succeeding Craig Cordola. The company highlighted her deep dialysis expertise and leadership, expressing confidence in her ability to drive operational execution and achieve mid-term financial aspirations for Care Delivery. Ms. McLean joined Fresenius Medical Care in August 2025 and previously held leadership roles at Monte Nido and DaVita Kidney Care.
Key Highlights
- Cassie McLean appointed to Fresenius Medical Care AG Management Board, effective August 1, 2026.
- Ms. McLean will serve as Chief Executive Officer of the Care Delivery operating segment.
- She succeeds Craig Cordola, who previously held the CEO of Care Delivery position.
- Ms. McLean joined Fresenius Medical Care in August 2025 as President, Fresenius Kidney Care.
- The role has been reshaped to create more direct accountability for operational execution and business performance.
- Prior to joining the company, Ms. McLean served as CEO of Monte Nido and spent nearly 16 years at DaVita Kidney Care.
Price Impact
More from FMS